Antares Pharma, Inc.
ATRSDelisted May 24, 2022- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001016169
Antares Pharma, Inc. was delisted on May 24, 2022; its insiders filed their last Form 4 on May 26, 2022; 177 institutions reported holding it in 13F filings for Q1 2022, worth $374.8M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Antares Pharma, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ATRS is no longer listed, and 13F filings after Q1 2022 list far fewer holders. See Q1 2022
- Institutional holders
- 0
- −1 vs. Q3 2022
- Shares held
- 0
- −4.37K (−100.0%) vs. Q3 2022
- Total value
- $0
- −$12.0K (−100.0%) vs. Q3 2022
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $12.0K |
| Q2 2022 | 1 | $12.0K |
| Q1 2022 | 177 | $374.8M |
| Q4 2021 | 163 | $305.5M |
| Q3 2021 | 171 | $300.0M |
| Q2 2021 | 175 | $358.2M |
| Q1 2021 | 171 | $339.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Antares Pharma, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% | −4,369−100.0% | Sold out |